CD36 and neoplasm: Tumors actively stimulate adipocyte lipolysis via the adipose triglyceride lipase (ATGL)-dependent pathway, leading to FFA release [22], which is transferred to cancer cells via CD36 or FATPs to fuel fatty acid oxidation (FAO) [23, 24], enhancing tumor aggressiveness.